Clinical Trial Update: Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans [Phase 3]

View source ↗

Summary

Phase 3 trial assessing nebivolol for hypertension in African American patients has completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Mylan Bertek Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED